Procedural success and complications of large-scale screening colonoscopy

Gastrointestinal Endoscopy

Volumn 55, Issue 3, 2002, Pages 307-314

  Nelson, Douglas B ^a,b   McQuaid, Kenneth R ^a,b   Bond, John H ^a,b   Lieberman, David A ^a,b   Weiss, David G ^a,b   Johnston, Tiina K ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CANCER SCREENING; CECUM; COLONOSCOPY; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PERFORATION; POLYP; PRIORITY JOURNAL; SYNCOPE; THROMBOPHLEBITIS; CLINICAL TRIAL; COLON POLYP; COLORECTAL TUMOR; HEART INFARCTION; MASS SCREENING; MIDDLE AGED; MULTICENTER STUDY; STANDARD;

AGED; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0036517087     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1067/mge.2002.121883     Document Type: Article

References (38)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36.
2. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365-71.
3. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised, controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;148:1472-7.
4. Kronborg O, Fenger C, Olsen J, Jøgensen OD, Søndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
5. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
6. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
7. Guide to clinical preventive services. 2nd ed. Report of the U.S. Preventive Services Task Force. Washington, DC: U.S. Dept. of Health and Human Services; 1995.
8. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
9. Rex D, Johnson D, Lieberman D, Burt R, Sonnenberg A. Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000;95:868-77.
10. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162-8.
11. Package insert. Fentanyl citrate injection, USP. Cheny Hill (NJ): Elkins-Sinn; 1991.
12. Package insert. Versed (midazolam HCI) injection. Nutley (NJ): Roche Laboratories; 1999.
13. Lieberman DA. Cost-effectiveness model for colon cancer screening. Gastroenterology 1995;109:1781-90.
14. Ness RM, Holmes AM, Klein R, Dittus R. Cost-utility of one-time colonoscopic screening for colorectal cancer at various ages. Am J Gastroenterol 2000;95:1800-11.
15. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;133:573-84.
16. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Steinberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
17. Atkin WS, Hart A, Edwards R, McIntyre P, Aubrey R, Wardle J, et al. Uptake, yield of neoplasia, and adverse effects of flexible sigmoidoscopy screening. Gut 1998;42:560-5.
18. Mandel JS, Church TR, Bond JH, Ederer F, Geisser MS, Mongin SJ, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000;343:1603-7.
19. Provenzale D, Homan RK, Oddone EZ. Screening colonoscopy in average risk individuals is cost-effective compared with other practices [abstract]. Am J Gastroenterol 1999;94:2683.
20. Waye JD, Bashkoff E. Total colonoscopy: is it always possible? Gastrointest Endosc 1991;37:152-4.
21. Marshall JB, Barthel JS. The frequency of total colonoscopy and terminal ileal intubation in the 1990s. Gastrointest Endosc 1993;39:518-20.
22. Church JM. Complete colonoscopy: how often? And if not, why not? Am J Gastroenterol 1994;89:556-60.
23. Cirocco WC. Factors that predict incomplete colonoscopy. Dis Colon Rectum 1995;38:964-8.
24. Kim WH, Cho YJ, Park JY, Mm PK, Kang JK, Park IS. Factors affecting insertion time and patient discomfort during colonoscopy. Gastrointest Endosc 2000;52:600-5.
25. Johnson DA, Gurney M, Volpe RJ, Jones D, VanNess MM, Chobanian SJ, et al. A prospective study of the prevalence of colonic neoplasms in asymptomatic patients with an age-related risk. Am J Gastroenterol 1990;85:969-74.
26. DiSario JA, Foutch PG, Mai HD, Pardy K, Manne RK. Prevalence and malignant potential of colorectal polyps in asymptomatic, average-risk men. Am J Gastroenterol 1991;86:941-5.
27. Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946-51.
28. Rex DK, Lehman GA, Ulbright TM, Smith JJ, Pound DC, Hawes RH, et al. Colonic neoplasia in asymptomatic persons with negative fecal occult blood tests: influence of age, gender, and family history. Am J Gastroenterol 1993;88:825-31.
29. Rogge JD, Elmore MF, Mahoney SJ, Brown ED, Troiano FP, Wagner DR, et al. Low-cost, office-based, screening colonoscopy. Am J Gastroenterol 1994;89:1775-80.
30. Kadakia SC, Wrobleski CS, Kadakia AS, Meier NJ. Prevalence of proximal colonic polyps in average-risk asymptomatic patients with negative fecal occult blood tests and flexible sigmoidoscopy. Gastrointest Endosc 1996;44:112-7.
31. Silvis SE, Nebel O, Rogers G, Sugawa C, Mandelstam P. Endoscopic complications: results of the 1974 American Society for Gastrointestinal Endoscopy (ASGE) survey. JAMA 1976;235:928-30.
32. Macrae FA, Tan KG, Williams CB. Toward safer colonoscopy: a report on the complications of 5000 diagnostic or therapeutic colonoscopies. Gut 1983;24:376-83.
33. Basson MD, Etter L, Panzini LA. Rates of colonoscopic perforation in current practice [letter]. Gastroenterology 1998;114:1115.
34. Eckardt VF, Kanzler G, Schmitt T, Eckardt AJ, Bernhard G. Complications and adverse effects of colonoscopy with selective sedation [letter]. Gastrointest Endosc 1999;49:560-5.
35. Zubarik R, Fleischer DE, Mastropietro C, Lopez J, Carroll J, Benjamin S, et al. Prospective analysis of complications 30 days after outpatient colonoscopy. Gastrointest Endosc 1999;50:322-8.
36. Anderson ML, Pasha TM, Leighton JA. Endoscopic perforation of the colon: lessons from a 10-year study. Am J Gastroenterol 2000;95:3418-22.
37. Ristikankare M, Hartikainen J, Heikkinen M, Janatuinen E, Julkunen R. The effects of gender and age on the colonoscopic examination. J Clin Gastroenterol 2001;32:69-75.
38. Anderson JC, Gonzalez JD, Messina CR, Pollack B. Factors that predict incomplete colonoscopy: thinner is not always better. Am J Gastroenterol 2000;95:2784-7.